126 related articles for article (PubMed ID: 38763038)
1. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
[TBL] [Abstract][Full Text] [Related]
2. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
[TBL] [Abstract][Full Text] [Related]
3. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
Zhang H; Jahng JWS; Liu Y; Chase AJ; Perez MV; Wu JC
Stem Cell Res; 2021 Aug; 55():102492. PubMed ID: 34411974
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
Lee Y; Park H; Kyung Koo S; Kim JH
Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanism and gene correction for LQTS-causing double mutations in KCNQ1 using a pluripotent stem cell model.
Wang Z; Wang L; Liu W; Hu D; Gao Y; Ge Q; Liu X; Li L; Wang Y; Wang S; Li C
Stem Cell Res; 2019 Jul; 38():101483. PubMed ID: 31226583
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation.
Ge N; Liu M; Ding Y; Krawczyk J; McInerney V; Galvin J; Shen S; Prendiville T; O'Brien T
Stem Cell Res; 2019 Dec; 41():101650. PubMed ID: 31765965
[TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell line (JSPHi002-A) from a patient with long-QT syndrome type 1 caused by KCNQ1 c.773A > T mutation.
Wang Q; Zhang Y; Zhang F; Li Z; Cheng H; Lin Y; Zhu Y; Chen H; Cui C; Chen M
Stem Cell Res; 2022 Jul; 62():102810. PubMed ID: 35580545
[TBL] [Abstract][Full Text] [Related]
8. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
[TBL] [Abstract][Full Text] [Related]
9. Suppression-Replacement
Dotzler SM; Kim CSJ; Gendron WAC; Zhou W; Ye D; Bos JM; Tester DJ; Barry MA; Ackerman MJ
Circulation; 2021 Apr; 143(14):1411-1425. PubMed ID: 33504163
[TBL] [Abstract][Full Text] [Related]
10. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
[TBL] [Abstract][Full Text] [Related]
11. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
Wang H; Guo T; Lan F
Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
[TBL] [Abstract][Full Text] [Related]
12. Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC) line (Long and Short QT Syndrome).
Wang B; Ren Q; Cui X; Shan W; Guo X; Wang X; Wang J; Li Y; An G
Stem Cell Res; 2024 Jun; 77():103400. PubMed ID: 38547667
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological phenotype in the LQTS mutations Y111C and R518X in the KCNQ1 gene.
Diamant UB; Vahedi F; Winbo A; Rydberg A; Stattin EL; Jensen SM; Bergfeldt L
J Appl Physiol (1985); 2013 Nov; 115(10):1423-32. PubMed ID: 24052033
[TBL] [Abstract][Full Text] [Related]
15. MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.
Lee YK; Sala L; Mura M; Rocchetti M; Pedrazzini M; Ran X; Mak TSH; Crotti L; Sham PC; Torre E; Zaza A; Schwartz PJ; Tse HF; Gnecchi M
Cardiovasc Res; 2021 Feb; 117(3):767-779. PubMed ID: 32173736
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment.
Wang F; Han Y; Sang W; Wang L; Liang X; Wang L; Xing Q; Guo Y; Zhang J; Zhang L; Zukela T; Xiaokereti J; Lu Y; Zhou X; Tang B; Li Y
Cells; 2022 Aug; 11(16):. PubMed ID: 36010573
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.
Lavra L; Magi F; Ulivieri A; Morgante A; Paulis M; Sala L; Pedrazzini M; Polisca P; Rocchetti M; Calò L; Sciacchitano S; Salehi LB
Stem Cell Res; 2021 Jul; 54():102418. PubMed ID: 34130155
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological properties of iPS cell-derived cardiomyocytes from a patient with long QT syndrome type 1 harboring the novel mutation M437V of KCNQ1.
Sogo T; Morikawa K; Kurata Y; Li P; Ichinose T; Yuasa S; Nozaki D; Miake J; Ninomiya H; Shimizu W; Fukuda K; Yamamoto K; Shirayoshi Y; Hisatome I
Regen Ther; 2016 Jun; 4():9-17. PubMed ID: 31245483
[TBL] [Abstract][Full Text] [Related]
19. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
[TBL] [Abstract][Full Text] [Related]
20. Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1.
Harmer SC; Mohal JS; Royal AA; McKenna WJ; Lambiase PD; Tinker A
Biochem J; 2014 Aug; 462(1):133-42. PubMed ID: 24912595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
